샘플 요청 목록

 카트 문의
시장보고서
상품코드
1944428

지속형 주사제(LAI) 시장 : 제품 종류별, 투여 경로별, 용도별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Long-acting injectables (LAIs) Market, By Product Type, By Route of Administration, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 365 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

지속형 주사제(LAI) 시장 규모는 2024년에 168억 6,030만 달러로 평가되었으며, 2025년부터 2032년까지 CAGR 13.01%로 확대될 전망입니다.

지속형 주사제(LAI)는 공압이나 유압 시스템이 아닌 전기 모터를 사용하여 물체를 파지, 고정, 해제하도록 설계된 로봇용 팔 끝단 장치입니다. 산업용 로봇, 협동 로봇, 자동화 설비에 폭넓게 적용되어 정확하고 신뢰할 수 있는 자재 취급을 실현합니다. 이 그리퍼는 손가락과 턱의 움직임을 정밀하게 제어하는 서보 모터 또는 스테핑 모터를 사용하여 작동하며, 파지력, 속도, 위치 결정 등을 조절할 수 있습니다. 이 정밀한 제어를 통해 높은 재현성과 정밀도를 실현하는 지속형 주사제(LAI)는 깨지기 쉬운 부품, 소형 부품, 불규칙한 형상의 부품을 취급하는 데 적합합니다.

지속형 주사제(LAI) 시장 역학

복약 순응도 향상과 만성질환의 높은 유병률이 시장 수요를 견인할 것으로 예상됩니다.

지속형 주사제(LAI)는 매일 복용하는 경구용 치료제 대비 복약 순응도를 크게 개선할 수 있어 LAI 시장의 성장을 촉진할 수 있습니다. 만성질환, 특히 정신분열증, 양극성 장애와 같은 정신질환은 복약순응도가 현저히 낮으며, 이는 질환의 재발, 잦은 입원, 의료비 증가로 이어집니다. LAI는 몇 주에서 몇 달에 걸쳐 지속적으로 약물을 방출하기 때문에 매일 약을 복용할 필요가 없으며, 체내에서 안정적인 치료 수준을 유지합니다. 이러한 간소화된 접근 방식은 치료 루틴을 단순화할 뿐만 아니라 재발 위험 감소, 입원 횟수 감소, 의료 시스템 전체에 대한 부담 경감에도 기여합니다. 주사 횟수를 줄임으로써 환자의 편의성을 높이고 장기적인 질병 관리를 지원하며, 의료진과 환자 모두에게 LAI가 점점 더 선호되는 선택이 되고 있습니다.

또한 정신질환, HIV/에이즈, 당뇨병, 호르몬 불균형 등 만성 및 장기적인 건강 상태의 유병률 증가도 시장 수요에 기여하고 있습니다. 전 세계적으로 고령화와 생활습관병이 확산됨에 따라 지속적이고 신뢰할 수 있는 치료법에 대한 수요가 빠르게 증가하고 있습니다. LAI는 정신질환, 만성감염증 등 약물 농도의 일관된 유지가 필수적이면서도 매일 경구약물 복용을 준수하기 어려운 질환의 관리에 특히 유용하게 활용될 수 있습니다. 수 주에서 수개월에 걸쳐 지속적인 약물 방출을 실현하는 LAI는 복약을 잊어버림에 따른 질병 진행 및 입원 위험 감소에 기여합니다. 또한, 이러한 만성질환 환자 수의 증가는 LAI의 잠재적 시장을 크게 확대하여 선진국과 신흥국 모두에서 강력한 수요를 견인하고 있습니다. 이러한 추세는 의료 제공자들이 '환자 치료 결과 개선', '의료 인프라 부담 감소', '장기적인 질병 관리 촉진'을 실현하는 솔루션을 선호하면서 더욱 강화되고 있습니다.

지속형 주사제(LAI) 시장 : 세분화 분석

세계 지속형 주사제(LAI) 시장은 제품 유형, 투여 경로, 적응증, 최종사용자, 지역에 따라 세분화되어 있습니다.

제품 유형에 따른 시장 분류는 항정신병약, 호르몬제, 항감염제, 기타 등 4개 카테고리로 나뉩니다. 2024년 기준 항정신병약 부문이 주요 점유율을 차지할 것으로 예상됩니다. 이 제제는 주로 정신분열증, 양극성 장애, 기타 만성 정신질환의 치료에 사용됩니다. 지속형 항정신병약물은 수 주에서 수개월 동안 안정적인 치료약물 농도를 유지하여 재발 위험을 낮추고 약물 농도 변동에 따른 부작용을 최소화합니다.

시장은 용도에 따라 정신질환, HIV/AIDS, 통증/만성질환, 내분비질환, 기타 등 5가지 카테고리로 분류됩니다. 정신질환 분야는 많은 환자 수, 질병의 만성적 특성, 경구용 약물의 복약 순응도 문제, 그리고 지속성 치료의 강력한 임상적 이점이 결합되어 LAI 시장을 선도하고 있습니다. LAI는 재발률, 입원율, 의료 시스템에 대한 전반적인 부담을 줄입니다. 이는 예측 가능하고 일관된 치료를 제공하며, 복용을 잊어버리면 심각한 결과를 초래할 수 있는 심각한 정신 질환에서 특히 중요합니다.

지속형 주사제(LAI) 시장 - 지역별 분석

북미는 현재 지속형 주사제(LAI) 시장을 선도하고 있습니다. 이는 정신의학 분야에서 LAI의 광범위한 채택, 탄탄한 의료 인프라, 종합적인 보험 적용, 그리고 혁신적인 치료법에 대한 조기 접근이 촉진요인으로 작용하고 있습니다. 미국은 지역 내 주요 기여국으로, 의료진과 환자 모두 LAI의 이점(치료 순응도 향상, 재발률 감소, 장기적인 질병 관리 최적화)에 대한 인식이 높아진 것이 기여하고 있습니다. 지속적인 제품 출시와 더 새롭고 편리한 제형의 가용성은 미국 시장을 더욱 강화시키고 있습니다. 유럽은 두 번째 시장 점유율을 차지하고 있으며, 독일, 프랑스, 영국 등의 국가들이 도입을 주도하고 있습니다. 이 지역의 성장은 체계적인 정신건강 프로그램, 만성 정신 질환 및 내분비 질환의 발생률 증가, 지속형 호르몬 요법에 대한 수요 증가에 의해 뒷받침되고 있습니다.

목차

제1장지속형 주사제(LAI) 시장 개요

제2장 주요 요약

제3장지속형 주사제(LAI)의 주요 시장 동향

제4장지속형 주사제(LAI) 시장 : 산업 분석

제5장지속형 주사제(LAI) 시장 : 높아지는 지정학적 긴장의 영향

제6장지속형 주사제(LAI) 시장 구도

제7장지속형 주사제(LAI) 시장 : 제품 종류별

제8장지속형 주사제(LAI) 시장 : 투여 경로별

제9장지속형 주사제(LAI) 시장 : 용도별

제10장지속형 주사제(LAI) 시장 : 최종사용자별

제11장지속형 주사제(LAI) 시장 : 지역별

제12장 주요 벤더 분석 : 지속형 주사제(LAI) 산업

제13장 AnalystView의 전방위적 분석

KSM 26.03.13

Long-acting injectables (LAIs) Market size was valued at USD 16,860.30 Million in 2024, expanding to a CAGR of 13.01% from 2025 to 2032.

A Long-acting injectables (LAIs) is a robotic end-of-arm device designed to pick, secure, and release objects by using electric motors rather than pneumatic or hydraulic systems. It is widely integrated with industrial robots, collaborative robots, and automated equipment for accurate and reliable material handling. These grippers function using servo or stepper motors that precisely control the movement of fingers or jaws, enabling adjustable gripping force, speed, and positioning. This precise control delivers high repeatability and accuracy, making Long-acting injectables (LAIs)s well suited for handling fragile, small, or irregularly shaped components.

Long-acting injectables (LAIs) Market- Market Dynamics

Improved medication adherence along with high prevalence of chronic disorders is anticipated to propel market demand

Long-acting injectables (LAIs) have the ability to significantly enhance medication adherence compared with daily oral treatments, boosting LAIs market growth. Chronic conditions, particularly psychiatric disorders such as schizophrenia and bipolar disorder, often face high rates of non-adherence, leading to disease relapse, frequent hospitalizations, and increased healthcare costs. LAIs provide a sustained release of medication over several weeks or months, eliminating the need for daily dosing and maintaining steady therapeutic levels in the body. This streamlined approach not only simplifies treatment routines but also reduces relapse risk, decreases hospital admissions, and alleviates the overall burden on healthcare systems. The reduced frequency of injections improves patient convenience, supports better long-term disease management, and makes LAIs an increasingly preferred option for both healthcare providers and patients.

Moreover, the rising prevalence of chronic and long-term health conditions, including psychiatric disorders, HIV/AIDS, diabetes, and hormonal imbalances also contributing to market demand. As global populations age and lifestyle-related illnesses become increasingly widespread, the need for therapies that provide continuous and reliable treatment is growing rapidly. LAIs are particularly advantageous in managing conditions where maintaining consistent drug levels is essential and where daily oral adherence is often difficult, such as in mental health or chronic infectious diseases. By offering sustained drug release over weeks or months, LAIs help mitigate the risks associated with missed doses, including disease progression and hospitalization. Moreover, the growing number of patients affected by these chronic conditions significantly expands the potential market for LAIs, driving strong demand across both developed and emerging regions. This trend is further reinforced by healthcare providers' preference for solutions that improve patient outcomes, reduce the burden on medical infrastructure, and promote long-term disease management.

Long-acting injectables (LAIs) Market- Segmentation Analysis:

The Global Long-acting injectables (LAIs) Market is segmented on the basis of Product Type, Route of Administration, Application, End User, and Region.

The market is divided into four categories based on Product Type: antipsychotics, hormonal agents, anti-infectives, and others. Antipsychotics segment hold major share in 2024. These formulations are primarily used to treat schizophrenia, bipolar disorder, and other chronic psychiatric conditions. Long-acting antipsychotics provide steady therapeutic drug levels over weeks or months, reducing the risk of relapse and minimizing side effects associated with fluctuating drug levels.

The market is divided into five categories based on Application: psychiatric disorders, HIV/AIDS, pain & chronic diseases, endocrine disorders, and others. Psychiatric disorders segment leads the LAI market due to the combination of large patient populations, chronic nature of illnesses, adherence challenges with oral medications, and strong clinical benefits of long-acting therapy. LAIs reduce relapse rates, hospital admissions, and the overall burden on healthcare systems. They provide predictable, consistent treatment, which is particularly important in severe psychiatric disorders where missed doses can have serious consequences.

Long-acting injectables (LAIs) Market- Geographical Insights

North America currently leads the Long-Acting Injectables (LAIs) market, driven by the widespread adoption of LAIs in psychiatric care, strong and well-established healthcare infrastructure, comprehensive insurance coverage, and early access to innovative therapies. The United States is the dominant contributor within the region, benefiting from increasing awareness among healthcare providers and patients about the advantages of LAIs in improving treatment adherence, reducing relapse rates, and optimizing long-term disease management. Continuous product launches and the availability of newer, more convenient formulations further strengthen the U.S. market. Europe holds the second-largest market share, with countries such as Germany, France, and the United Kingdom leading in adoption. The region's growth is supported by structured mental health programs, rising incidence of chronic psychiatric and endocrine disorders, and increasing demand for long-acting hormonal therapies.

United States- Long-acting injectables (LAIs) Market- Key Insights

The United States region growth is fueled by widespread use in psychiatric care, a strong healthcare infrastructure, and comprehensive insurance coverage. Millions of Americans are affected by chronic psychiatric disorders, such as schizophrenia and bipolar disorder, creating substantial demand for treatments that enhance medication adherence and reduce the risk of relapse. LAIs deliver medication gradually over weeks or months, maintaining stable therapeutic levels, minimizing hospitalizations, and supporting effective long-term disease management. Market growth is further driven by ongoing product innovation, including newer antipsychotic formulations with extended dosing intervals, improved tolerability, and more convenient modes of administration. Increased awareness among healthcare professionals and patients about the clinical advantages and cost-effectiveness of LAIs also accelerates adoption.

Long-acting injectables (LAIs) Market- Competitive Landscape:

The Long-Acting Injectables (LAIs) market in 2025 is moderately competitive, driven by leading global pharmaceutical companies that prioritize product innovation, therapeutic expansion, and strategic market launches. Johnson & Johnson, Pfizer continues to hold major revenue shares, offering a comprehensive portfolio of LAIs across psychiatric and oncology indications. The company's focus on enhancing patient adherence through robust support programs, educational initiatives, and convenient dosing schedules strengthens its market leadership and ensures consistent revenue growth. Both companies are setting benchmarks for innovation, while ongoing competition drives accelerated development of novel delivery technologies and patient-centric solutions, making the LAI sector one of the most dynamic segments in pharmaceuticals today.

Recent Developments:

In 2025, Lupin obtained U.S. FDA approval for its risperidone long-acting injectable, which also received 180-day Competitive Generic Therapy (CGT) exclusivity. This formulation is the first product developed under Lupin's PrecisionSphere LAI technology platform, showcasing the company's innovation in sustained-release injectable therapies.

In December 2025, Teva Pharmaceuticals filed a New Drug Application (NDA) with the U.S. FDA for its olanzapine extended-release injectable suspension (TEV-749), designed as a once-monthly therapy for adults living with schizophrenia.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET KEY PLAYERS

  • Johnson & Johnson
  • Pfizer
  • Eli Lilly
  • ViiV Healthcare
  • Teva Pharmaceuticals
  • Alkermes
  • Lupin Limited
  • Amneal Pharmaceuticals
  • Sanofi
  • Novartis
  • Bristol-Myers Squibb
  • GlaxoSmithKline (GSK)
  • AbbVie
  • Roche
  • Sun Pharmaceutical Industries
  • Others

GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • Antipsychotics
  • Hormonal agents
  • Anti-infectives
  • Others

GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019-2032

  • Intramuscular
  • Intravenous (IV)
  • Subcutaneous

GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Psychiatric disorders
  • HIV/AIDS
  • Pain & chronic diseases
  • Endocrine disorders
  • Others

GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinics & Specialty Centers
  • Others

GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Long-acting injectables (LAIs) Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Long-acting injectables (LAIs) Market Snippet by Product Type
    • 2.1.2. Long-acting injectables (LAIs) Market Snippet by Route of Administration
    • 2.1.3. Long-acting injectables (LAIs) Market Snippet by Application
    • 2.1.4. Long-acting injectables (LAIs) Market Snippet by End User
    • 2.1.5. Long-acting injectables (LAIs) Market Snippet by Country
    • 2.1.6. Long-acting injectables (LAIs) Market Snippet by Region
  • 2.2. Competitive Insights

3. Long-acting injectables (LAIs) Key Market Trends

  • 3.1. Long-acting injectables (LAIs) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Long-acting injectables (LAIs) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Long-acting injectables (LAIs) Market Opportunities
  • 3.4. Long-acting injectables (LAIs) Market Future Trends

4. Long-acting injectables (LAIs) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Long-acting injectables (LAIs) Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Long-acting injectables (LAIs) Market Landscape

  • 6.1. Long-acting injectables (LAIs) Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Long-acting injectables (LAIs) Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Antipsychotics
    • 7.1.3. Hormonal agents
    • 7.1.4. Anti-infectives
    • 7.1.5. Others

8. Long-acting injectables (LAIs) Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
    • 8.1.2. Intramuscular
    • 8.1.3. Intravenous (IV)
    • 8.1.4. Subcutaneous

9. Long-acting injectables (LAIs) Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Psychiatric disorders
    • 9.1.3. HIV/AIDS
    • 9.1.4. Pain & chronic diseases
    • 9.1.5. Endocrine disorders
    • 9.1.6. Others

10. Long-acting injectables (LAIs) Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics & Specialty Centers
    • 10.1.4. Others

11. Long-acting injectables (LAIs) Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Long-acting injectables (LAIs) Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Long-acting injectables (LAIs) Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Long-acting injectables (LAIs) Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Long-acting injectables (LAIs) Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Long-acting injectables (LAIs) Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Long-acting injectables (LAIs) Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Johnson & Johnson
    • 12.2.2. Pfizer
    • 12.2.3. Eli Lilly
    • 12.2.4. ViiV Healthcare
    • 12.2.5. Teva Pharmaceuticals
    • 12.2.6. Alkermes
    • 12.2.7. Lupin Limited
    • 12.2.8. Amneal Pharmaceuticals
    • 12.2.9. Sanofi
    • 12.2.10. Novartis
    • 12.2.11. Bristol-Myers Squibb
    • 12.2.12. GlaxoSmithKline (GSK)
    • 12.2.13. AbbVie
    • 12.2.14. Roche
    • 12.2.15. Sun Pharmaceutical Industries
    • 12.2.16. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제